XML 32 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating expenses:    
Research and development $ 12,522 $ 12,032
General and administrative 9,687 4,487
Total operating expenses 22,209 16,519
Loss from operations (22,209) (16,519)
Other income:    
Interest income 82 213
Total other income 82 213
Net loss (22,127) (16,306)
Comprehensive loss $ (22,127) $ (16,306)
Net loss per share attributable to common stockholders—basic and diluted $ (2.59) $ (82.23)
Weighted-average common shares outstanding—basic and diluted 8,590,205 202,093